Your browser doesn't support javascript.
loading
The Efficacy and Safety of Rivaroxaban and Dalteparin in the Treatment of Cancer Associated Venous Thrombosis.
Chaudhury, Ateefa; Balakrishnan, Asha; Thai, Christy; Holmstrom, Bjorn; Nanjappa, Sowmya; Ma, Zhenjun; Jaglal, Michael V.
Afiliação
  • Chaudhury A; 1Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612 USA.
  • Balakrishnan A; 2Department of Internal Medicine, Division of Hematology and Medical Oncology, University of South Florida, Tampa, FL USA.
  • Thai C; 3Department of Internal Medicine, University of South Florida, Tampa, FL USA.
  • Holmstrom B; 4Department of Pharmacy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA.
  • Nanjappa S; 5Department of Internal Hospital Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA.
  • Ma Z; 5Department of Internal Hospital Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA.
  • Jaglal MV; 6Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA.
Indian J Hematol Blood Transfus ; 34(3): 530-534, 2018 Jul.
Article em En | MEDLINE | ID: mdl-30127566

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article